Kyle Melin to Risk Assessment
This is a "connection" page, showing publications Kyle Melin has written about Risk Assessment.
Connection Strength
0.071
-
Nu?ez-Medina HJ, Monero M, Torres LM, Leal E, Gonzalez-Sepulveda L, Mayor ?M, Renta JY, Gonz?lez-Garc?a ER, Gonz?lez A, Melin K, Scott SA, Rua?o G, Hernandez-Suarez DF, Duconge J. Implementing a pharmacogenomic-driven algorithm to guide antiplatelet therapy among Caribbean Hispanics: a non-randomised clinical trial. BMJ Open. 2024 09 05; 14(9):e084119.
Score: 0.044
-
Hernandez-Suarez DF, Scott SA, Tomey MI, Melin K, Lopez-Candales A, Buckley CE, Duconge J. Clinical determinants of clopidogrel responsiveness in a heterogeneous cohort of Puerto Rican Hispanics. Ther Adv Cardiovasc Dis. 2017 Sep; 11(9):235-241.
Score: 0.027